ASPEN PHARMACARE HOLDINGS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up
APN
ZAE000066692
Pharmaceuticals End-of-day quote Johannesburg S.E. Other stock markets | 5-day change | 1st Jan Change | ||
213.7 ZAR | -1.38% | -4.33% | +5.03% |
Mar. 08 | Aspen Pharmacare Holdings Limited Announces Board Changes | CI |
Mar. 05 | Aspen Pharmacare Holdings Limited Seeks Acquisitions | CI |
Financials
Sales 2024 * | 44.7B 0 | Sales 2025 * | 50.91B 0 | Capitalization | 95.1B 0 |
---|---|---|---|---|---|
Net income 2024 * | 6.44B - | Net income 2025 * | 8.26B - | EV / Sales 2024 * | 2.59x |
Net Debt 2024 * | 20.83B 0 | Net Debt 2025 * | 18.56B 0 | EV / Sales 2025 * | 2.23x |
P/E ratio 2024 * | 15.4x | P/E ratio 2025 * | 11.7x | Employees | 8,887 |
Yield 2024 * | 1.67% | Yield 2025 * | 2.01% | Free-Float | 60.05% |
More Fundamentals * Assessed data
Chart Aspen Pharmacare Holdings Limited
Dynamic Chart
Latest news about Aspen Pharmacare Holdings Limited
Aspen Pharmacare Holdings Limited Announces Board Changes | CI | |
Aspen Pharmacare Holdings Limited Seeks Acquisitions | CI | |
Transcript : Aspen Pharmacare Holdings Limited, H1 2024 Earnings Call, Mar 05, 2024 | ||
Aspen Pharmacare expects FY mid-single digit earnings growth | RE | |
Aspen Pharmacare Holdings Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI | |
Aspen Pharmacare Holdings Limited Announces Changes to its Board | CI | |
Sandoz Signs Deal with Aspen Pharmacare to Sell Chinese Unit, Buy Four Anesthetic Products in Europe | MT | |
South Africa's Aspen Pharmacare to buy Sandoz's China business | RE | |
Transcript : Aspen Pharmacare Holdings Limited - Special Call | ||
Transcript : Aspen Pharmacare Holdings Limited - Special Call | ||
SA'S COMPETITION TRIBUNAL APPROVES DEAL WHERE ASPEN PHARMACARE T… | RE | |
China health sector sees better sentiment from anti-graft drive - execs | RE | |
Inflation Data, Central Bank Meeting Focus Send South African Stocks Lower | MT | |
Novo Nordisk Announces Partnership to Establish Insulin Production in South Africa | DJ | |
South African Stocks in the Green Ahead of US Fed's Rate Meeting | MT |
More news
Latest transcript on Aspen Pharmacare Holdings Limited
Aspen Pharmacare Holdings Limited, H1 2024 Earnings Call, Mar 05, 2024
More transcripts
Analyst Recommendations on Aspen Pharmacare Holdings Limited
South African Stocks in the Green Ahead of US Fed's Rate Meeting | MT | |
Australian Shares Continue to Rise as RBA Holds Rates | MT |
More recommendations
Press releases Aspen Pharmacare Holdings Limited
Aspen announces additional pharmaceutical donations for Ukranian patients | AQ | |
Aspen concludes two significant agreements with Sandoz for China and Europe | AQ | |
Aspen Pharmacare : 2023 Capital Markets Day - NDB, France | PU | |
Aspen Pharmacare : Integrated Report - view online version | PU | |
Aspen announces contract manufacturing agreement to initiate local production of Human Insulin for Novo Nordisk at its Gqeberha based sterile manufacturing facility | AQ |
More press releases
News in other languages on Aspen Pharmacare Holdings Limited
Pharma und Gesundheit: weitere Konsolidierung | ||
Farma en gezondheid: consolidatie gaat door | ||
Farmaceutica e salute: continua il consolidamento | ||
Farmacia y salud: La consolidación continúa | ||
Pharma & santé : poursuite de la consolidation |
More news
Quotes and Performance
1 day | -1.38% | ||
1 week | -4.33% | ||
Current month | -2.57% | ||
1 month | -0.70% | ||
3 months | +10.00% | ||
6 months | +30.82% | ||
Current year | +5.03% |
More quotes
Highs and lows
1 week
210.20
224.20
1 month
210.20
224.99
Current year
185.41
224.99
1 year
160.96
224.99
3 years
128.89
281.67
5 years
64.07
281.67
10 years
64.07
448.68
More quotes
Managers and Directors - Aspen Pharmacare Holdings Limited
Managers | Title | Age | Since |
---|---|---|---|
Stephen Saad FOU | Founder | 60 | - |
Sean Capazorio DFI | Director of Finance/CFO | 57 | 98-12-31 |
Lorraine Angela Hill COO | Chief Operating Officer | 60 | 98-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Christopher Mortimer BRD | Director/Board Member | 63 | 98-12-31 |
Stephen Saad FOU | Founder | 60 | - |
Kuseni Dlamini CHM | Chairman | 53 | 12-03-31 |
More insiders
ETFs positioned on Aspen Pharmacare Holdings Limited
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
KRANESHARES EMERGING MARKET HEALTHCARE INDEX ETF - DISTRIBUTING - USD | 1.49% | 2 M€ | -14.14% |
More ETFs positioned on Aspen Pharmacare Holdings Limited
Quotes
Date | Price | Change | Volume |
---|---|---|---|
24-04-23 | 213.7 | -1.38% | 1,012,338 |
24-04-22 | 216.7 | -0.13% | 1,127,287 |
24-04-19 | 217 | -1.00% | 939,528 |
24-04-18 | 219.2 | -2.16% | 1,463,383 |
24-04-17 | 224 | +0.28% | 1,394,794 |
End-of-day quote Johannesburg S.E., April 22, 2024
More quotes
Company Profile
Aspen Pharmacare Holdings Limited is the African leading pharmaceutical group. The group's products are primarily for the treatment of asthma, HIV, bacterial infections, gastro-intestinal, respiratory and inflammatory diseases. Net sales break down by family of products as follows:- pharmaceuticals (71.6%): anaesthetics products, thrombosis products, cytotoxic products, etc.;- other (28.4%): infant nutrition products and consumer products.At the end of June 2022, the group had 16 production sites worldwide.
Sector
Pharmaceuticals
Calendar
2024-09-02 - Q4 2024 Earnings Release
More about the company
Income Statement Evolution
More financial data
Ratings for Aspen Pharmacare Holdings Limited
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Analysts' Consensus
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
213.7ZAR
Average target price
227.7ZAR
Spread / Average Target
+6.54%
Consensus
EPS Revisions
Estimates Revisions
Quarterly earnings - Rate of surprise
Company calendar
Sector Generic Pharmaceuticals
1st Jan change | Capi. | |
---|---|---|
ASPEN PHARMACARE HOLDINGS LIMITED | +5.03% | 4.97B |
SUN PHARMACEUTICAL INDUSTRIES LTD. | +18.49% | 42.77B |
OTSUKA HOLDINGS CO., LTD. | +20.21% | 22.23B |
SANDOZ GROUP AG | +13.05% | 14.44B |
CIPLA LIMITED | +10.94% | 13.05B |
ZYDUS LIFESCIENCES LIMITED | +35.10% | 11.59B |
ONO PHARMACEUTICAL CO., LTD. | -8.80% | 6.95B |
THE MEDICINES COMPANY | -0.05% | 6.79B |
STADA ARZNEIMITTEL | -8.87% | 5.73B |
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD. | -6.46% | 4.6B |
Generic Pharmaceuticals
- Stock Market
- Equities
- APN Stock